Parkinson's disease Centogene Strikes Deals With Premier Research, Denali Therapeutics for Clinical Trials Centogene will work with Premier to offer rare disease clinical trial support services and has extended a Parkinson's disease-focused alliance with Denali. Parkinson's Foundation Taps Tag.bio for PD GENEration Data Sharing, Analysis The foundation will use Tag.bio's software to link anonymized clinical and genomic datasets to research Parkinson's disease causes and personalized treatment. Metabolon, Parkinson's UK Form Biomarker Discovery Alliance Metabolon will participate in a Parkinson's UK-funded study to map metabolic changes in serum that can serve as biomarkers of disease progression. Qiagen, Neuron23 Partner for NGS-Based Parkinson's Disease Companion Diagnostic The collaboration will expand Qiagen's NGS testing portfolio for precision medicine beyond oncology into neurology applications. PD GENEration Parkinson's Study Expands Test Sites, Minority Reach Premium Twenty-three out of 50 planned study sites are now active, and a partnership with Morehouse School of Medicine will help with minority recruitment. Nov 2, 2021 Valted Seq Raises $10.5M Seed Funding May 6, 2021 Parkinson's Disease Progression Linked to Five Variants in Genome-Wide Survival Study Apr 29, 2021 Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays Apr 15, 2021 Centogene Q4 Revenues Grow Almost Fivefold, Driven by COVID-19 Testing Jan 22, 2021 Microba, University of Queensland Partner to Study Gut Microbiome in Parkinson's Disease Jan 7, 2021 Genuity Science, Emory Team on Biomarker Discovery for Neurodegenesis Nov 18, 2020 Ardigen, BioCollective Partner to Discover Metagenomic Biomarkers of Parkinson's Disease Oct 21, 2020 Sanofi Commits $1M to Support Parkinson's Disease Genetic Testing Study Oct 13, 2020 Single-Cell Parkinson's Disease Study Reveals Dopamine Neuron Cell Type-Specific Perturbations Aug 26, 2020 MedGenome, Denali Therapeutics Form Parkinson's Disease Research Alliance May 14, 2020 Erisyon Wins $189K Michael J. Fox Foundation Grant for Protein Biomarker Discovery Apr 27, 2020 Parkinson's Disease Cellular Genetic Analysis Uncovers Unexpected Role for Oligodendrocytes Feb 4, 2020 Cellectricon, StressMarq Ink Neurodegenerative Disease Research Deal Dec 11, 2019 Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling Oct 24, 2019 New Parkinson's Disease RNA-Seq Dataset Enables Search for Disease Biomarkers Premium Aug 28, 2019 Johns Hopkins, NanoView Biosciences Using EVs to ID HIV-Related Neurological Disorder Biomarkers Premium Jul 18, 2019 Parkinson's Disease Relationship to Oral Microbiome Being Explored for Diagnostic Potential Premium Jul 17, 2019 Parkinson's Foundation Project Seeks to ID Patient Disease Variants to Guide Therapy Premium Jul 16, 2019 Parkinson's Foundation, Fulgent Genetics Partner on Genetic Testing Initiative May 13, 2019 Centogene, University of Lübeck to Investigate Genetics of Parkinson's Disease Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.